TrialJournal of Crohn's & colitis2016

Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.

William J Sandborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.